Abbott Laboratories vs. Obsidian Therapeutics, Inc. Common Stock
ABT
Abbott Laboratories
$110.78 -2.48%
VS OBXObsidian Therapeutics, Inc. Common Stock
$13.87 +44.43%
Abbott Laboratories and Obsidian Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | OBX | |
|---|---|---|
| Market Cap | $196.75 billion | $593.02 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | OBX | |
|---|---|---|
| Dividend Yield | 2.27% | — |
ABT and OBX split the dividend factors evenly.
Risk & Sentiment
| ABT | OBX | |
|---|---|---|
| Short Interest | 0.57% | 0.06% |
OBX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, OBX overview, OBX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.